aMoon Fund

About The Fund

aMoon Fund is a venture capital firm headquartered at 3075 Townsgate Road, Suite 140, Westlake Village, California, 91361, United States. However, it is also based in Ra'anana, Israel. The firm specializes in equity investments, focusing on the sectors of healthcare devices, pharmaceuticals, biopharma, life sciences, health tech, oncology, and digital health. With assets under management of $320 million, aMoon Fund invests in early to late-stage companies, including seed, startup, early stage, Series A, Series B, Series C, and Pre-IPO ventures. They typically invest anywhere from $100,000 to $5,000,000, with an investment sweet spot of around $1,500,000. aMoon is committed to accelerating the convergence of technology and biology, which they believe is transforming healthcare. They partner with exceptional scientists and entrepreneurs, seeking to build great companies and expedite the cure for high unmet medical needs. Through aMoon Velocity and aMoon Growth, they invest in early and late-stage companies pursuing disruptive solutions. Their team comprises scientists, physicians, entrepreneurs, and investors who are passionate about making healthcare more affordable and improving access to care. aMoon operates not just as a funding source but also as an enabler, providing support through their aMoon Alpha team, which aids in unlocking additional value creation opportunities for portfolio companies. Additionally, they run a global talent engine, a bridges program connecting portfolio companies with key ecosystem players, and engage in proprietary research for investment intelligence. Their website also indicates that they value trust, a foundational element rooted in the name aMoon, derived from Hebrew. They pursue ambitious, moonshot projects, approaching what might seem impossible with a vision of possibility.